Par Ingemar Jo­hans­son

Par Ingemar Jo­hans­son

Clinical Professor

Member of:

  • Clinical immunology


  1. 2020
  2. Published

    Low dose Iloprost effect on platelet aggregation in comatose out-of-hospital cardiac arrest patients: A predefined sub-study of the ENDO-RCA randomized -phase 2- trial

    Meyer, A. S. P., Ostrowski, Sisse Rye, Kjærgaard, J., Frydland, M., Thomsen, J. H., Jo­hans­son, Pär In­ge­mar & Hassager, Christian, 2020, In: Journal of Critical Care. 56, p. 197-202 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    “Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): Safety and efficacy of low-dose Iloprost, a prostacyclin analogue, in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arrest-syndrome patients.”

    Meyer, A. S. P., Jo­hans­son, Pär In­ge­mar , Kjaergaard, J., Frydland, M., Meyer, M. A. S., Henriksen, H. H., Thomsen, J. H., Wiberg, S. C., Hassager, Christian & Ostrowski, Sisse Rye, 2020, In: American Heart Journal. 219, p. 9-20 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 232690472